These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 34736908)

  • 21. A systematic review of COX-2 inhibitors compared with traditional NSAIDs, or different COX-2 inhibitors for post-operative pain.
    Rømsing J; Møiniche S
    Acta Anaesthesiol Scand; 2004 May; 48(5):525-46. PubMed ID: 15101847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Parecoxib Sodium in the Multimodal Analgesia after Total Knee Arthroplasty: A Randomized Double-blinded Controlled Trial.
    Bian YY; Wang LC; Qian WW; Lin J; Jin J; Peng HM; Weng XS
    Orthop Surg; 2018 Nov; 10(4):321-327. PubMed ID: 30485685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Effectiveness of Intravenous Parecoxib on the Incidence of Ipsilateral Shoulder Pain After Thoracotomy: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Pipanmekaporn T; Punjasawadwong Y; Charuluxananan S; Lapisatepun W; Bunburaphong P; Boonsri S; Tantraworasin A; Bunchungmongkol N
    J Cardiothorac Vasc Anesth; 2018 Feb; 32(1):302-308. PubMed ID: 29223722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the effects of parecoxib and diclofenac in preemptive analgesia: A prospective, randomized, assessor-blind, single-dose, parallel-group study in patients undergoing elective general surgery.
    Bajaj P; Ballary CC; Dongre NA; Baliga VP; Desai AA
    Curr Ther Res Clin Exp; 2004 Sep; 65(5):383-97. PubMed ID: 24672093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The analgesic efficacy of intramuscular parecoxib sodium in postoperative dental pain.
    Mehlisch DR; Desjardins PJ; Daniels S; Hubbard RC
    J Am Dent Assoc; 2004 Nov; 135(11):1578-90. PubMed ID: 15622663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous parecoxib and continuous femoral block for postoperative analgesia after total knee arthroplasty. A randomized, double-blind, prospective trial.
    Sarridou DG; Chalmouki G; Braoudaki M; Koutsoupaki A; Mela A; Vadalouka A
    Pain Physician; 2015; 18(3):267-76. PubMed ID: 26000670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of parecoxib on postoperative pain after lumbar spine surgery: a bicenter, randomized, double-blinded, placebo-controlled trial.
    Jirarattanaphochai K; Thienthong S; Sriraj W; Jung S; Pulnitiporn A; Lertsinudom S; Foocharoen T
    Spine (Phila Pa 1976); 2008 Jan; 33(2):132-9. PubMed ID: 18197096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial.
    Seinstra BA; Defreyne L; Lambert B; Lam MG; Verkooijen HM; van Erpecum KJ; van Hoek B; van Erkel AR; Coenraad MJ; Al Younis I; van Vlierberghe H; van den Bosch MA
    Trials; 2012 Aug; 13():144. PubMed ID: 22913492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind, randomized comparison of intramuscularly and intravenously administered parecoxib sodium versus ketorolac and placebo in a post-oral surgery pain model.
    Daniels SE; Grossman EH; Kuss ME; Talwalker S; Hubbard RC
    Clin Ther; 2001 Jul; 23(7):1018-31. PubMed ID: 11519767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sorafenib in combination with transarterial chemoembolization improves the survival of patients with unresectable hepatocellular carcinoma: a propensity score matching study.
    Bai W; Wang YJ; Zhao Y; Qi XS; Yin ZX; He CY; Li RJ; Wu KC; Xia JL; Fan DM; Han GH
    J Dig Dis; 2013 Apr; 14(4):181-90. PubMed ID: 23324079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis.
    Takayasu K; Arii S; Ikai I; Kudo M; Matsuyama Y; Kojiro M; Makuuchi M;
    AJR Am J Roentgenol; 2010 Mar; 194(3):830-7. PubMed ID: 20173167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduction in opioid-related adverse events and improvement in function with parecoxib followed by valdecoxib treatment after non-cardiac surgery: a randomized, double-blind, placebo-controlled, parallel-group trial.
    Langford RM; Joshi GP; Gan TJ; Mattera MS; Chen WH; Revicki DA; Chen C; Zlateva G
    Clin Drug Investig; 2009; 29(9):577-90. PubMed ID: 19663520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraarterial lidocaine administration for relief of pain resulting from transarterial chemoembolization of hepatocellular carcinoma: its effectiveness and optimal timing of administration.
    Lee SH; Hahn ST; Park SH
    Cardiovasc Intervent Radiol; 2001; 24(6):368-71. PubMed ID: 11907741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of parecoxib on analgesia benefit and blood loss following open prostatectomy: a multicentre randomized trial.
    Dirkmann D; Groeben H; Farhan H; Stahl DL; Eikermann M
    BMC Anesthesiol; 2015; 15():31. PubMed ID: 25767411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unresectable Hepatocellular Carcinoma: Radioembolization Versus Chemoembolization: A Systematic Review and Meta-analysis.
    Lobo L; Yakoub D; Picado O; Ripat C; Pendola F; Sharma R; ElTawil R; Kwon D; Venkat S; Portelance L; Yechieli R
    Cardiovasc Intervent Radiol; 2016 Nov; 39(11):1580-1588. PubMed ID: 27586657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pain Management Using Perioperative Administration of Parecoxib for Total Hip Arthroplasty: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Xiao K; Yu L; Xiao W; Peng H; Bian Y; Wu Z; Weng X
    Pain Physician; 2019 Nov; 22(6):575-582. PubMed ID: 31775404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parecoxib sodium reduces the need for opioids after tonsillectomy in children: a double-blind placebo-controlled randomized clinical trial.
    Li X; Zhou M; Xia Q; Li J
    Can J Anaesth; 2016 Mar; 63(3):268-74. PubMed ID: 26684457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation - HeiLivCa [ISRCTN24081794].
    Hoffmann K; Glimm H; Radeleff B; Richter G; Heining C; Schenkel I; Zahlten-Hinguranage A; Schirrmacher P; Schmidt J; Büchler MW; Jaeger D; von Kalle C; Schemmer P
    BMC Cancer; 2008 Nov; 8():349. PubMed ID: 19036146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases.
    Swierz MJ; Storman D; Riemsma RP; Wolff R; Mitus JW; Pedziwiatr M; Kleijnen J; Bala MM
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009498. PubMed ID: 32163181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparison of doxorubicin-eluting bead transarterial chemoembolization (DEB-TACE) with conventional transarterial chemoembolization (TACE) for the treatment of hepatocellular carcinoma].
    Ferrer Puchol MD; la Parra C; Esteban E; Vaño M; Forment M; Vera A; Cosín O
    Radiologia; 2011; 53(3):246-53. PubMed ID: 21295802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.